Bedrocan Danmark ApS - CVR: 43238779

2022, DKK

29.06.2023

Bruttoresultat

-1.010'

Primær drift

-1.010'

Årets resultat

-793'

Aktiver

22.479'

Kortfristede aktiver

21.479'

Egenkapital

21.557'

Afkastningsgrad

-4 %

Soliditetsgrad

96 %

Likviditetsgrad

+500%

Resultat

29.06.2023

Årsrapport	2022 29.06.2023
Nettoomsætning
Bruttoresultat	-1.009.823
Resultat af primær drift	-1.009.823
Indtægter af kapitalandele (tilknyttede og associerede)	0
Finansielle indtægter	0
Finansieringsomkostninger	-7.239
Andre finansielle omkostninger	0
Resultat før skat	-1.017.062
Resultat	-793.308
Forslag til udbytte	0

Aktiver

29.06.2023

Årsrapport	2022 29.06.2023
Kortfristede varebeholdninger	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	403.740
Likvider	21.075.299
Kortfristede aktiver	21.479.039
Immaterielle aktiver og goodwill	0
Finansielle anlægsaktiver	1.000.000
Materielle aktiver	0
Langfristede aktiver	1.000.000
Aktiver	22.479.039

Aktiver

29.06.2023

Passiver

29.06.2023

Årsrapport	2022 29.06.2023
Forslag til udbytte	0
Egenkapital	21.556.792
Hensatte forpligtelser	0
Langfristet gæld til banker	0
Leverandører af varer og tjenesteydelser	899.932
Kortfristede forpligtelser	922.247
Gældsforpligtelser	922.247
Forpligtelser	922.247
Passiver	22.479.039

Passiver

29.06.2023

Nøgletal

29.06.2023

Årsrapport	2022 29.06.2023
Afkastningsgrad	-4,5 %
Dækningsgrad	Na.
Resultatgrad	Na.
Varelagerets omsætningshastighed	Na.
Egenkapitals-forretning	-3,7 %
Payout-ratio	Na.
Gældsdæknings-nøgletal	-13.949,8 %
Soliditestgrad	95,9 %
Likviditetsgrad	2.329,0 %

Resultat

29.06.2023

Gæld

29.06.2023

Årsrapport

29.06.2023

Nyeste:25.04.2022- 31.12.2022(offentliggjort: 29.06.2023)

Information om virksomhedens regnskabsklasse:The annual report has been prepared in accordance with Danish financial statements legislation as well as generally accepted accounting principles. The annual report of Bedrocan Danmark ApS for 2022 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B, with the adoption of individual rules from class C.

Beretning

29.06.2023

Dato for ledelsens godkendelse af årsrapporten:2023-06-28

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of Bedrocan Danmark ApS for the financial year 25 April 2022 - 31 December 2022. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2022 and of the results of the Company's operations for the financial year 25 April 2022 - 31 December 2022. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. We recommend that the Annual Report be adopted at the Annual General Meeting. Copenhagen, 28 June 2023 Executive Board Jacob Leendert Erkelens Hans Rudolf Spits Man. Director Chief Financial Officer

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of Bedrocan Danmark ApS for the financial year 25 April 2022 - 31 December 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The Company’s objects are to conduct business within cultivating, finishing, storing, packaging and supplying cannabis products for medical purposes.